Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer
Cancer Science · 2023
DOI: 10.1111/cas.15869 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Sheng-Fan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Cisplatin, Stomach Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Melissa Lee Cancer Foundation, National Science and Technology Council, Taiwan, Taipei Veterans General Hospital.
Abstract (Originalsprache)
Gastric cancer is a common cancer worldwide, particularly in East Asia. Chemotherapy is used in adjuvant or palliative therapies for gastric cancer. However, subsequent chemoresistance often develops. Growth differentiation factor 15 (GDF15) links to several cancers, but its effect on chemoresistance in gastric cancer remains unclear. Here, we analyzed clinical samples from genetic databases and included patients with gastric cancer. We dissected the regulatory mechanism underlying GDF15‐mediated resistance of cisplatin in human gastric cancer cells. We showed that GDF15 serum levels might be a valuable biomarker for predicting prognosis in gastric cancer. The expressions of GDF15 and its receptor glial cell‐derived neurotrophic factor family receptor a‐like (GFRAL) in gastric tumors are important for malignant progression. Moreover, GDF15 expression is increased in gastric cancer cells with cisplatin resistance, resulting from elevated intracellular glutathione (GSH) and antioxidant activities. Upregulated GDF15 could increase intracellular GSH content by activating the GFRAL‐GCN2‐eIF2α‐ATF4 signaling, enhancing cystine‐uptake transporter xCT expression, and contributing biosynthesis of GSH in human gastric cancer cells. In conclusion, our results indicate that GDF15 could induce chemoresistance by upregulating xCT expression and GSH biosynthesis in human gastric cancer cells. Targeting GDF15 could be a promising treatment method for gastric cancer progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Taipei Veterans General Hospital, Taipei, Taiwan.
- Department of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taipei, Taiwan.
- Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Faculty of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Division of General Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
ORCID-Profile: Sheng-Fan Wang
Förderung
- Melissa Lee Cancer Foundation
- National Science and Technology Council, Taiwan
- Taipei Veterans General Hospital
Zitieren
APA
Wang, S. F., Chang, Y. L., Fang, W. L., Li, A. F., Chen, C. F., Yeh, T. S., Hung, G. Y., Huang, K. H., & Lee, H. C. (2023). Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer. Cancer Science. https://doi.org/10.1111/cas.15869
Vancouver
Wang SF, Chang YL, Fang WL, Li AF, Chen CF, Yeh TS, et al. Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer. Cancer Science. 2023. doi:10.1111/cas.15869
BibTeX
@article{Wang2023,
author = {Wang, Sheng-Fan and Chang, Yuh-Lih and Fang, Wen-Liang and Li, Anna Fen-Yau and Chen, Chian-Feng and Yeh, Tien-Shun and Hung, Giun-Yi and Huang, Kuo-Hung and Lee, Hsin-Chen},
title = {Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15869}
}
EUVIMED